Skip to main content
. 2020 Nov 4;5(6):e000979. doi: 10.1136/esmoopen-2020-000979

Table 2.

Location of first disease relapse at a distant site

Group A (≤12 months) n=201
No. (%)
Group B (>12 months) n=203
No. (%)
P value
Type of metastatic presentation (distant relapse)* 0.195
 Visceral 139 (69) 128 (63)
 Non-visceral 62 (31) 75 (37)
Metastatic site (distant relapse)† 0.073
 Brain 52 (26) 31 (15)
 Liver 46 (23) 60 (30)
 Lung 37 (18) 33 (16)
 Bone 43 (21) 51 (25)
 Others 23 (11) 28 (14)
 Type of metastatic presentation (distant relapse)* 0.289
 Visceral 139 (77) 128 (72)
 Bone (without visceral) 42 (23) 50 (28)

*Patients with bone, skin, lymph node and soft tissue were considered as non-visceral; all the others were considered as visceral.

†For patients who developed relapse in more than one organ, the first site of distant metastasis was defined by prespecified importance in the following order: brain, liver, lung, bone and others. The category ‘others’ included: skin, lymph node, soft tissue, pleura and other rarer sites of relapse.